Search

Your search keyword '"Gural, Alexander"' showing total 15 results
Start Over Author "Gural, Alexander" Publication Year Range Last 3 years
15 results on '"Gural, Alexander"'

3. Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial

Author

Lee, Jong Wook, primary, Griffin, Morag, additional, Kim, Jin Seok, additional, Lee Lee, Lily Wong, additional, Piatek, Caroline, additional, Nishimura, Jun-ichi, additional, Carrillo Infante, Cynthia, additional, Jain, Deepak, additional, Liu, Peng, additional, Filippov, Gleb, additional, Sicre de Fontbrune, Flore, additional, Risitano, Antonio, additional, Kulasekararaj, Austin G, additional, Barcellini, Wilma, additional, Barraco, Fiorenza, additional, Beneitez Pastor, David, additional, Capra, Marcelo, additional, Chew, Lee Ping, additional, Chrysavgi, Lalayanni, additional, De Castro, Carlos, additional, de la Tour, Régis Peffault, additional, De Oliveira, Michel Michels, additional, Di Bona, Eros, additional, Forcade, Edouard, additional, Fu, Chieh-Lin, additional, Furha, Cossor, additional, Gaya Valls, Anna, additional, Giannouli, Stavroula, additional, Gonzalez-Fernandez, Ataulfo, additional, Gural, Alexander, additional, Gutierrez, Emilio Ojeda, additional, Hernández-Rodríguez, Inés, additional, Ibrahim, Ibrahim, additional, Iori, Anna Paola, additional, Ishida, Tadao, additional, Jang, Jun Ho, additional, Kim, Jeong-A, additional, Kitano, Toshiyuki, additional, Kosugi, Hiroshi, additional, Kreiniz, Natalia, additional, Kulasekararaj, Austin, additional, Lee, Jong Wook, additional, Mayer, Jiri, additional, Mitchell, Lindsay, additional, Mori, Yasuo, additional, Nishiwaki, Kaichi, additional, Notaro, Rosario, additional, Nunez, Ramiro, additional, Obara, Naoshi, additional, Oliva, Esther Natalie, additional, Patriquin, Christopher, additional, Pessoa, Viviani, additional, Piekarska, Agnieszka, additional, Raza, Shahzad, additional, Risitano, Antonio Maria, additional, Rojnuckarin, Ponlapat, additional, Samuel, Desmond, additional, Shammo, Jamile, additional, Tadmor, Tamar, additional, Takami, Akiyoshi, additional, Tamari, Roni, additional, Terriou, Louis, additional, Uchiyama, Hitoji, additional, Vannucchi, Alessandro Maria, additional, and Yamaguchi, Hiroki, additional

Published
2023
Full Text
View/download PDF

10. Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma

Author

Lebel, Eyal, primary, Goldschmidt, Neta, additional, Siegal, Tali, additional, Lossos, Alexander, additional, Rosenberg, Shai, additional, Makranz, Chen, additional, Linetski, Eduard, additional, Gatt, Moshe E., additional, Gural, Alexander, additional, Saban, Revital, additional, Lavie, David, additional, Vainstein, Vladimir, additional, Zimran, Eran, additional, Avni, Batia, additional, Grisaro, Sigal, additional, Shaulov, Adir, additional, and Nachmias, Boaz, additional

Published
2022
Full Text
View/download PDF

14. case series of eosinophilic myocarditis: different faces of the same coin.

Author

Mengesha, Bethlehem, Meir, Karen, Gural, Alexander, and Asleh, Rabea

Subjects
MYOCARDITIS, SYMPTOMS, TREATMENT delay (Medicine), COINS, CARDIOVASCULAR diseases
Abstract

Background Eosinophilic myocarditis (EM) is a rare form of myocarditis with various aetiologies and dire consequences if not diagnosed and treated expeditiously. Case summary We report three cases of EM at different stages of the disease with differing clinical manifestations. We highlight the diagnostic workup including the role of multimodality imaging and endomyocardial biopsy (EMB), and the treatment strategies. Discussion EM is an underdiagnosed and potentially life-threatening disease. Therefore, a high clinical suspicion for EM should arise when patients with signs and symptoms of cardiovascular disease develop hypereosinophilia or vice versa. Early identification of this condition using multimodality imaging and EMB is of paramount importance as the disease may progress to the irreversible late fibrotic stage if treatment is delayed. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

15. Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia in Association with Antiphospholipid Syndrome.

Author

Gelman, Ram, Kharouf, Fadi, Ishay, Yuval, and Gural, Alexander

Subjects
AUTOIMMUNE hemolytic anemia, ANTIPHOSPHOLIPID syndrome, COMPLEMENT activation, HEMOLYTIC anemia
Abstract

Antiphospholipid syndrome and cold agglutinin-mediated autoimmune hemolytic anemia are 2 distinct immune-mediated hematologic disorders. While no clear association exists between these 2 entities, complement activation is known to occur in both of them. Herein, we report a unique case of cold agglutinin hemolytic anemia in a patient with a known primary antiphospholipid syndrome. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results